[Research Report] Mexico's Medical Device and IVD Import Market

Download Full Report (110 Pages)

‍

‍Competitive Landscape: A Shifting Global Balance

The competitive environment is largely defined by the enduring dominance of the United States, which remains the principal supplier to Mexico. In 2024, U.S. imports were valued at $5.78 billion, accounting for a 50.7% market share. However, this leadership position is facing increasing pressure.

The primary challenger is Greater China (including the Mainland, Hong Kong, Macau, and Taiwan), which has firmly secured its position as the second-largest supplier. In 2024, imports from this region reached $1.63 billion, capturing a 14.3% market share on the back of impressive 26.8% year-over-year growth.

European nations, particularly Germany and Italy, are also making significant gains. Germany, the third-largest partner, commanded a 7.9% market share in 2024 with imports of $898.2 million, following a massive 94.2% value surge in 2023. Italy has emerged as a particularly aggressive competitor, with its exports to Mexico growing by an explosive 70.9% in 2024 to reach $455.5 million.

‍

Medical Specialty Segments: Key Growth Engines

Analysis of the market by medical specialty highlights the key drivers of demand. The General & Plastic Surgery category is the undisputed foundation of the market, with imports reaching a staggering $5.19 billion in 2024 and showing steady 16.3% growth. This reflects the high volume of routine surgical procedures and a thriving medical tourism sector for cosmetic interventions.

Beyond this core segment, several high-technology specialties are experiencing explosive growth:

1. Ophthalmic Devices: This market saw imports accelerate dramatically, growing 49.0% in 2024 to reach $1.14 billion. This is fueled by an aging population, a high prevalence of diabetes-related eye conditions, and strong demand from medical tourists.
2. Ear, Nose, & Throat (ENT) Devices: This segment has been a star performer, with import values surging 197.7% in 2023 and another 44.5% in 2024. This reflects rapid technological adoption in a specialized field.
3. Radiology: Driven by a major public and private sector push to modernize healthcare infrastructure, imports in this category jumped 91.2% in 2023 to nearly $900 million.

‍

Regulatory Modernization and Strategic Imperatives

Underpinning these market trends is a landmark regulatory transformation by Mexico's health authority, COFEPRIS. Historically a significant barrier, the regulatory process is being modernized to align with global standards. The most impactful change is the new COFEPRIS 2025 Abbreviated Regulatory Pathway, which will fast-track approvals for devices already cleared by major international bodies part of the IMDRF (Australia, Brazil, Canada, China, the European Union, Japan, Russia, Singapore, South Korea, the United Kingdom, and the United States) or MDSAP (Australia, Brazil, Canada, Japan, and the United States) member states.

Report Q&A
Here are four key questions the report answers:

1. Who is the largest supplier of medical devices to Mexico by a significant margin?
   Answer: The United States is the largest supplier, holding a 50.7% share of the import market in 2024.
2. Which specific medical specialty represents the largest segment of the import market?
   Answer: General & Plastic Surgery is the largest segment by far, with imports valued at $5.19 billion in 2024.
3. What is the single most important regulatory change making it easier for foreign companies to enter the Mexican market?
   Answer: The new COFEPRIS 2025 Abbreviated Regulatory Pathway, which leverages prior approvals from major global regulators to significantly reduce time-to-market.
4. Which high-tech specialty has shown the most dramatic growth acceleration in the most recent year?
   Answer: Ophthalmic devices, which saw import growth accelerate to 49.0% in 2024, reaching a value of $1.14 billion.

Interesting Facts from the Report

• The "Maquiladora Paradox": Mexico is a top-10 global exporter of medical devices, producing sophisticated products for the world. Yet, it simultaneously relies on imports for over 80% of the devices used in its own domestic healthcare system.
• Extreme Tender-Driven Volatility: The market for Clinical Chemistry devices experienced an unprecedented value swing, dropping 94% in 2022 and then surging by 2,696% in 2023.
• The Rise of ENT: While larger categories grew steadily, the specialized market for Ear, Nose, & Throat (ENT) devices experienced explosive growth, more than quadrupling in value from $68.5 million in 2022 to $294.9 million in 2024.

‍